CW September 2004
Volume 13Issue Number 9 September 2004 ISSN 10593802 Extended Bisphosphonate Therapy in Advanced Prostate CancerA trial of extended bisphosphonate therapy shows continued or increasing benefits in advanced prostate cancer patients, including those who have already experienced a skeletal-related event (SRE).
Go to Previous Page Go to Next Page Source & Additional Reading F. Saad, speaking at the 40th Annual Meeting of the American Society of Clinical Oncology. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW September 2004Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
